Dear friends,
Six months ago, I decided to share a few of our consult cases on Twitter in order to promote the consult service and give it an opportunity to grow. The plan was to share one case a week, but as it turned out, discussing interesting cases…
@DaniBeckman
Amazing as always. Unfortunately, as Jonathan Swift so eloquently said: Reasoning will never make a man correct an ill opinion, which by reasoning he never acquired.
One in a million Monday. First of all, my apologies to all placental pathologists reading this tweet, this is not personal, your work is noble, and you are appreciated. But I can't say I'm a fan of placental pathology. The reason is the times placental pathology provides any…
One in a million Monday.
Unwittingly saved by the clinician. This case was not a consult, it was just a good old biopsy from a satellite hospital for whose patients we provide pathology diagnostic services. In that hospital, breast surgeons coordinate breast patient care,…
Welcome to my Twitter account where I will be sharing my experience and thoughts from difficult cases received on the WASHU breast consultation service. Questions and comments always welcome. We learn together.
#PathTwitter
#BreastPathology
@wusm_pathology
@washupathedu
Dear pathology community, I am being held hostage by a mob of six unstable juveniles and their leader. I have no access to pathology cases or slides and I’m being coerced into enjoying the Christmas spirit. Please organize a rescue mission promptly. My diagnostic livelihood is on…
Sunday musings. Five things I have learned over the years, cemented by the consult service, that every pathologist should consider when releasing diagnoses into the wilderness.
1. Pathologists are morphologists, yes, but much more importantly, they are consultants. Findings that…
One in a million Monday.
Today we’re bridging two subspecialties
#breastpath
and
#hemepath
in a rare and unusual case. This is a middle aged patient with known left breast cancer, now presenting with a right sided breast mass and axillary lymph node. Both breast and lymph node…
My mentors David Page and Jean Simpson used to tell me this. High-power pathology, low-power pathologist. And this is of course very true. You do not want to get lost in the minutiae because they will steer you off track, most of the time that is. Sometimes though, a closer look…
Thank you all for your spot-on responses.
This is indeed a myofibroblastoma in a 75-year-old male patient. This palisaded pattern is quite rare in my experience and in this particular case was very prominent and strongly suggestive of Schwannian tumors. Schwannomas, though they…
Papillary lesions are a hairy affair! How would you characterize this papillary proliferation with preserved myoepithelial cells? No poll this time, and I am not quizzing, I am asking for help :)
@wusm_pathology
@washupathedu
#PathTwitter
#breastpath
One in a million Monday.
This case stayed on my desk and made the rounds multiple times for several days because it is unlike any case I have ever seen. Cystic hypersecretory spaces, TDLU-like architecture, relatively bland cytology, this lesion was screaming benign off the top…
Don't cross these flimsy Roman bridges toward a diagnosis of atypical hyperplasia. They will crumble under your feet. UDH mimicking ADH. Key findings: streaming overlapping variable nuclei and non-rigid arches
#BreastPath
#PathTwitter
@wusm_pathology
@washupathedu
Thank you all for your comments. As I expected, the responses were mixed, but ADH was a clear winner in the first case, in part driven by the need and recommendations to be more conservative in our core biopsy diagnoses, and in part because of the presence of two cell…
Friday staging mini-Tweetorial!
Staging in breast cancer is a subject dear to my heart that I feel is often confusing and misunderstood. The reason is simple. On a slide, we see things in two dimensions, and therefore we are taught in two dimensions and we come to remember and…
My story with solid papillary carcinoma (SPC) is marginally interesting, so I will go ahead and share it with you innocent onlooking victims 🙂
SPC was first described by Dr. Horacio Maluf in an AJSP paper in 1995 (which I shall go back to towards the end of this tweet). Yet,…
Let’s discuss the PASH vs. Fibroadenoma post.
PASH is a very popular entity. Just like stromal fibrosis, residents and attendings love to throw it in the mix of benign diagnoses in a biopsy report.
But I’m not a fan.
To be fair, it does have a clever name, a catchy acronym,…
Friday mini-Tweetorial! Part 2
Question: Is the absence of myoepithelial staining equivalent to invasion?
Answer: No.
Explanation: We cannot equate a lack of myoepithelial staining with invasion, first because lack of staining does not mean a lack of myoepithelial cells,…
Adenomyoepitheliomas are rare, challenging, biphasic neoplasms with a real potential for atypical change and malignant transformation. My mentor, David Page, would beg to differ because he was the most benign pathologist to ever walk the face of the earth. In my experience, about…
Going back to the UDH/DCIS differential may feel like beating a dead horse. But the cases keep coming and the implications are considerable. Yesterday's tweet illustrated a case diagnosed as DCIS by a skilled and experienced pathologist who was made acutely aware of his mistake…
Easing into Monday morning with an eye-catching histologic pattern, uncommonly seen in this mammary neoplasm. What is your differential diagnosis? What IHC panel would you like to perform?
@wusm_pathology
#PathTwitter
#Breastpath
Thank you all for your participation and for helping me demonstrate a very helpful finding when it comes to differentiating invasive vs. non-invasive disease.
The image depicts invasive carcinoma with DCIS-like morphology circling and impinging on a normal duct. The distribution…
Benign morphology, almost benign biology in the breast, often deadly biology in the salivary gland.
The conundrums of neoplasia will never be resolved.
#breastpath
#PathTwitter
@wusm_pathology
Gratitude Sunday.
This is Dr. Jean Simpson with my son Karl. She was in St. Louis for the weekend and stopped by to say hi.
Jean is not only the reason I am tweeting this, but the reason this Twitter account exists. She’s also the reason I am a breast pathologist.
She and…
Thank you all for your input. The problem with a diagnosis of papillary DCIS is the diffuse presence of myoepithelial cells in the fibrovascular cores, which should not happen in a neoplastic papillary proliferation. In this case, I elected to still go for DCIS based on the…
I heard late Dr. Juan Rosai during a course he gave in Italy joke about the need to combine breast and prostate pathology once and for all. It was funny, and of course, partly true. The attached images are from a biopsy that shows literally five atypical glands lacking…
Happy Labor Day to the most industrious organ, producer of the elixir of life, the reason we exist as a species, the breast.
- Lactational change in a breastfeeding woman.
I have been avoiding this topic for a while, but I think it’s time to ease into it. This may take a couple or more tweets, it certainly deserves a few. So let’s get right into it with this pictorial introduction.
ADH or DCIS? and very importantly, why?
Talk to you soon!…
Peripheral slit-like spaces and a glomeruloid architecture are indicative of usual ductal hyperplasia, until they're not.
Here's some glomeruloid intermediate-grade ductal carcinoma in situ for your eyes to feast on.
#PathTwitter
#breastpath
@wusm_pathology
@washupathedu
Tuesday’s quiz was not fair, because it was not intended to get a correct answer but to illustrate two things. First, the importance of context, second the limitations of morphology.
1. Context is everything. A lion at the zoo is not a lion in the living room, a swimsuit on the…
Context is everything.
One of the stories I often tell my trainees is that, as an intern, I saw a tripolar mitosis, the most perfect I had and have ever seen, right at the edge of... a gouty tophus. I was so excited I shared it with my attendings and got a good laugh out of…
Thank you all for participating in yesterday’s case.
It is indeed a complex fibroadenoma with both atypical ductal hyperplasia (I did not pull the trigger on DCIS) and atypical lobular hyperplasia. This is a very rare combination although atypia in a fibroadenoma is common…
Beautiful Low-grade DCIS with rosettes and central necrosis.
1. Please don't call this comedonecrosis, it may imply a higher-grade more aggressive process.
2. Remember that comedo carcinoma, coined by Dr. Bloodgood in 1934, refers to a gross finding in mastectomies when…
Metaplastic carcinoma of the breast can take on a variety of different morphologies, and I have seen pseudovascular patterns with the acantholytic variant of squamous cell carcinoma, but I have never seen the epithelial/glandular component of a metaplastic carcinoma adopt a…
Friday Mini-Tweetorial: Part Deux continued
3. Reptilian heads, or dinosaur heads if you're like my son, which refers to UDH nuclei with a central long groove and an eccentric nucleolus in lieu of the mouth and eye. I used a similar analogy for papillary thyroid carcinoma, and…
Morphologic Monday
This consult case is on an older woman with a palpable breast mass. Appropriately, the differential diagnosis of the consulting pathologist is metaplastic carcinoma, malignant phyllodes tumor, and primary sarcoma.
Immunohistochemistry is non contributory.…
Thank you all for voting. Briefly, half of 230 participants diagnosed this focus as ADH, a quarter diagnosed it as UDH with apocrine change, and the remainder were split.
The issue with this case (I do not claim to know the final answer) is that I cannot identify a clonal…
The diagnosis for yesterday’s case is LCIS with collagenous spherulosis. This case is particularly rich in myoepithelial cells, hence the many p63 positive nuclei and the excessive E-cadherin positivity obscuring the negative lobular cells. This amplifies the pitfall of calling…
When my 3-year-old daughter was throwing a tantrum yesterday at a breakfast place in Chicago, I tried, for once, to be a better, calmer parent.
I carried her outside to beautiful weather and stood by a small park where pigeons were picking their breakfast in the grass under a…
Thank you all, as always, for your comments and interactions. What a lonely place Twitter/X would have been if we were to share cases and get crickets.
This biopsy came to me with a preliminary diagnosis of nodular fasciitis, and I wasn't opposed to that interpretation, but…
Not all that glitters is gold! This is a biopsy from a 2 cm mass that was called metaplastic carcinoma by yours truly based on histologic pattern and positive p63 and cytokeratin. Excision followed and low and behold...
Sunday reflections.
When I interview applicants for medical school, I ask them what is the most important quality for a physician to have. The most common response I get is empathy, which is a good answer. But the answer I look for but I never get is humility.
Five reasons…
Friday Xposé 🤓
We’re all familiar with the difficulty in properly classifying fibroepithelial lesions of the breast.
Distinguishing fibroadenoma (FA) from benign phyllodes tumor (PT) is what we struggle with most often, and that’s because most of us accept the idea of a…
The case I posted yesterday is a resection on a biopsy that was called LCIS.
The key in this case of lobular neoplasia is to remember that E-cadherin, though often weaker than in epithelial cells, is usually retained in myoepithelial cells and its complete absence should make…
Thank you all for the outstanding responses! This is indeed crystal storing histiocytosis (CSH) with a main differential of granular cell tumor. Exceedingly rare in the breast, CSH can affect any organ and is usually associated with lymphoproliferative disorders and plasmacytic…
Vascular lesions, mammary or otherwise, can be quite daunting for several reasons. Malignant tumors can look benign, benign tumors can have necrosis and brisk mitotic activity, and heterogeneity is to be expected, which makes diagnosing a vascular neoplasm on core biopsy all the…
As a follow up to yesterday’s post, CK5/6 and ER are not very useful and can be confusing when the intraductal proliferation consists of a pure population of intermediate and high grade nuclei. DCIS can show basal-like immunophenotype (CK5/6 positive) and can be ER variable to…
Let's open the doors of controversy. My relationship with E-cadherin is strained, to say the least, and I will often rehash my thoughts on this matter to whoever is willing to listen and read. To me, lobular and ductal phenotypes are far from black-and-white varieties with…
It is wise to remember (and remind clinicians) that morphologic overlap in pathology is a rule that cannot be broken. Keeping an open mind about unconventional patterns of disease and recalling them for future reference is the very essence of expertise.
Behold the gynecomastoid…
As many of you have pointed out, this tumor is composed of malignant epithelium and malignant stroma, which is diagnostic of metaplastic carcinoma, and more specifically carcinosarcoma given the collision and lack of smooth transition between the carcinomatous and sarcomatous…
In my last tweet, two-thirds of the participants correctly diagnosed the focus depicted in the image as non-invasive, despite the lack of myoepithelial cells. The reason is that the focus lies within the previous biopsy site environment (fat necrosis, reactive fibrosis,…
Moving on with another example of tumors with a dual cell population.
This is the most famous of the bunch, classic adenoid cystic carcinoma.
In contrast to yesterday’s highly infiltrative tumor, this one is, contrary to expectations, well circumscribed, which is what prompted…
I can’t call this a Tweetorial because of the inherent controversy of the subject matter, so I’ll just call it a Saturday opinion piece.
Let’s get granular with lobular. The images I shared a couple of days ago show what to me looks like ALH/LCIS in a duct, and invasive lobular…
Let’s kick off the new year with everyone’s favorite tumor, the infamous invasive lobular carcinoma masquerading as something it isn’t.
One of the first cases I shared in April of last year was a lobular cancer that looked like fat necrosis. That one was scary, but it doesn’t…
Head-scratcher Tuesday.
This consult case befuddled me for a long time until I did one thing.
Here’s the story it came with. Latin American lady with a retroareolar mass, possibly painful but unsure, slow growing over the past 2-3 years.
Let the guesses and work-ups begin!…
Back to the basics Tuesday.
This patient has extensive high grade DCIS, but that’s not the question.
The question is: how many ducts and how many lobular units do you see in this low power (2x) snapshot?
Is it all ducts? Is it one big TDLU? is it one duct and multiple…
Wrapping up my
#BSTpath
week with this cutie. Not in the breast this time, for a change.
Subungual painful mass, came with a clinical diagnosis of glomus tumor. But glomus tumors have a very characteristic image in my mind with prominent vasculature and sheets of the most…
Subtle infiltrative patterns of invasive carcinoma are not always lobular. Sometimes ductal is just as sneaky and treacherous. The key here is to train your eye to recognize on low power slight deviations from normal and mild increases in cellularity, then zoom in and identify.…
There is something fundamentally wrong with the way we stage breast cancer, split survival curves notwithstanding.
I just signed out a high-grade invasive carcinoma that measures 50 mm, not 51 mm, so it is a T2 tumor. Is this cancer truly closer in behavior to one that is 21 mm…
The French say it best: En medecine comme en amour, ni jamais ni toujours. Meaning that in medicine (pathology in this case) just like in romance, there's never always and never never (butchered it but you get the gist).
This case is a nice illustration showcasing features of…
Today marks the first anniversary of my joining the
#PathTwitter
#breastpath
community. Funny how quickly a year passes by. Although I started out with daily posts and frequent tweetorials, things have slowed down a bit for me on the platform because they got busier in other…
Alright. This is a horrendous first attempt, but I’ll share it nonetheless to get as much feedback as possible. Be brutally honest with negative comments, because if you’re not honest, no one benefits.
If I’m going to do this I want to get it right, otherwise I’ll stick to…